Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Vaccine|November 13, 2018
Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: A descriptive studyChristina E Hoeve, Anja van Haren, Miriam C J M Sturkenboom, et al.Drug Safety|October 17, 2019
Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European UnionChristina E Hoeve, Reynold D C Francisca, Inge Zomerdijk, et al.Drug Safety|December 28, 2020
Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant FactorsChristina E Hoeve, Esther de Vries, Peter G M Mol, et al.Pharmacoepidemiology and Drug Safety|December 27, 2017
Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?Alexandra C Pacurariu, Christina E Hoeve, Peter Arlett, et al.Scientific Reports|October 26, 2023
Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoproteinGerco den Hartog, Stijn P Andeweg, Christina E Hoeve, et al.Vaccine|March 10, 2020
Fatal outcomes following immunization errors as reported to the EudraVigilance: A case seriesChristina E Hoeve, Kartini Gadroen, Marcel S G Kwa, et al.Drug Safety|October 1, 2020
Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in EuropeReynold D C Francisca, Emna Baba, Christina E Hoeve, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 21, 2024
Association between adverse events after COVID-19 vaccination and anti-SARS-CoV-2 antibody concentrations, the Netherlands, May 2021 to November 2022: a population-based prospective cohort studyMinke R Holwerda, Christina E Hoeve, Anne J Huiberts, et al.The Journal of Infectious Diseases|April 24, 2023
Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022Christina E Hoeve, Brechje de Gier, Anne J Huiberts, et al.Drug Safety|October 17, 2019
Exploratory Study of Signals for Asthma Drugs in Children, Using the EudraVigilance Database of Spontaneous ReportsEsmé J Baan, Veronique A de Smet, Christina E Hoeve, et al.Pageof 2